A strategy for accelerating the development of preventive AIDS vaccines
Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis
Long-term HIV-1 infection of neural progenitor populations
Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults
Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
Frequent detection of acute HIV infection in pregnant women
Serological testing algorithm shows rising HIV incidence in a UK cohort of men who have sex with men: 10 years application
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
Sexual network structure and the spread of HIV in Africa: evidence from Likoma Island, Malawi
HIV seroprevalence in street youth, St Petersburg, Russia
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen
Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients
High rate of extensively drug-resistant tuberculosis in Indian AIDS patients
Do CD8+CD25+ cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART?
Same race and older partner selection may explain higher HIV prevalence among black men who have sex with men
Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003–2006
Primary penile angiosarcoma in a patient with AIDS: a case report
Response to Brown et al., ‘Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe’
Atazanavir crystal nephropathy
Geographical biases and convenience sampling in HIV molecular epidemiology estimates
Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention
Hepatic involvement with tuberculosis-associated immune reconstitution disease
Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy
Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity